MX2009008518A - Compuestos y composiciones como inhibidores de la proteasa activadora de canal. - Google Patents
Compuestos y composiciones como inhibidores de la proteasa activadora de canal.Info
- Publication number
- MX2009008518A MX2009008518A MX2009008518A MX2009008518A MX2009008518A MX 2009008518 A MX2009008518 A MX 2009008518A MX 2009008518 A MX2009008518 A MX 2009008518A MX 2009008518 A MX2009008518 A MX 2009008518A MX 2009008518 A MX2009008518 A MX 2009008518A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- channel activating
- compositions
- protease inhibitors
- activating protease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
La invención proporciona compuestos y composiciones farmacéuticas de los mismos, los cuales son útiles para modular las proteasas activadoras de canal, y métodos para utilizar tales compuestos con el fin de tratar, disminuir, o prevenir una condición asociada con una proteasa activadora de canal, íncluyendo, pero no limitándose a prostasina, PRSS22, TMPRSS11 (por ejemplo, TMPRSS11B, TMPRSS11E), TMPRSS2, TMPRSS3, TMPRSS4 (MTSP-2), matriptasa (MTSP-1), CAP2, CAP3, tripsina, catepsina A, o elastasa de neutrófilos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88901807P | 2007-02-09 | 2007-02-09 | |
PCT/US2008/050403 WO2008097676A1 (en) | 2007-02-09 | 2008-01-07 | Compounds and compositions as channel activating protease inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009008518A true MX2009008518A (es) | 2009-08-20 |
Family
ID=39323929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009008518A MX2009008518A (es) | 2007-02-09 | 2008-01-07 | Compuestos y composiciones como inhibidores de la proteasa activadora de canal. |
Country Status (11)
Country | Link |
---|---|
US (1) | US8293915B2 (es) |
EP (1) | EP2117537A1 (es) |
JP (1) | JP2010518099A (es) |
KR (1) | KR20090108131A (es) |
CN (1) | CN101600428A (es) |
AU (1) | AU2008214217B2 (es) |
BR (1) | BRPI0807483A2 (es) |
CA (1) | CA2677487A1 (es) |
EA (1) | EA016327B1 (es) |
MX (1) | MX2009008518A (es) |
WO (1) | WO2008097676A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007137080A2 (en) | 2006-05-23 | 2007-11-29 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
JP2010518099A (ja) | 2007-02-09 | 2010-05-27 | アイアールエム・リミテッド・ライアビリティ・カンパニー | チャネル活性化プロテアーゼ阻害剤としての化合物および組成物 |
AR076880A1 (es) | 2009-05-18 | 2011-07-13 | Orion Corp | Inhibidores de proteasa, composiciones farmaceuticas que los contienen y su uso. |
KR20140049020A (ko) * | 2011-07-26 | 2014-04-24 | 사노피 | 치환된 3-(티아졸-4-카보닐)- 또는 3-(티아졸-2-카보닐)아미노프로피온산 유도체 및 이의 약제로서의 용도 |
US8729061B2 (en) * | 2011-11-25 | 2014-05-20 | Hoffmann-La Roche Inc. | Pyrrolidine derivatives |
JOP20190245A1 (ar) | 2017-04-20 | 2019-10-15 | Novartis Ag | أنظمة توصيل إطلاق مستدام تتضمن روابط بلا أثر لنقطة الربط |
AR116566A1 (es) | 2018-10-03 | 2021-05-19 | Novartis Ag | Administración sostenida de polipéptidos similares a la angiopoyetina 3 |
JP2023500182A (ja) | 2019-09-17 | 2023-01-05 | メレオ バイオファーマ 4 リミテッド | 移植片拒絶反応、閉塞性細気管支炎症候群、及び移植片対宿主病の治療に使用するためのアルベレスタット |
FI4106757T3 (fi) | 2020-04-16 | 2023-10-23 | Mereo Biopharma 4 Ltd | Neutrofiilien elastaasin inhibiittori alvelestaattia sisältäviä menetelmiä alfa-1-antitrypsiinipuutoksen välittämän hengityselintaudin hoitamiseksi |
CA3234399A1 (en) | 2021-10-20 | 2023-04-27 | Mereo Biopharma 4 Limited | Neutrophil elastase inhibitors for use in the treatment of fibrosis |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8809316D0 (en) | 1987-05-11 | 1988-05-25 | Ici America Inc | Heterocyclic ketones |
US5672582A (en) | 1993-04-30 | 1997-09-30 | Merck & Co., Inc. | Thrombin inhibitors |
JP3623799B2 (ja) * | 1994-06-02 | 2005-02-23 | アベンティス・ファーマスーティカルズ・インコーポレイテッド | 新しいエラスターゼ阻害剤 |
JPH0820597A (ja) | 1994-07-07 | 1996-01-23 | Meiji Seika Kaisha Ltd | トロンビン阻害作用を有する複素環カルボニル化合物 |
US5618792A (en) * | 1994-11-21 | 1997-04-08 | Cortech, Inc. | Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
US5710130A (en) * | 1995-02-27 | 1998-01-20 | Eli Lilly And Company | Antithrombotic agents |
US6211154B1 (en) * | 1995-06-07 | 2001-04-03 | Cor Therapeutics, Inc. | Ketoheterocyclic inhibitors of factor Xa |
US5523308A (en) * | 1995-06-07 | 1996-06-04 | Costanzo; Michael J. | Peptidyl heterocycles useful in the treatment of thrombin related disorders |
US5827866A (en) | 1995-06-07 | 1998-10-27 | Ortho Pharmaceutical Corporation | Peptidyl heterocycles useful in the treatment of thrombin related disorders |
US6069130A (en) | 1995-06-07 | 2000-05-30 | Cor Therapeutics, Inc. | Ketoheterocyclic inhibitors of factor Xa |
US5827860A (en) | 1995-06-07 | 1998-10-27 | Ortho Pharmaceutical Corporation | Peptidyl heterocycles useful in the treatment of thrombin related disorders |
US6022861A (en) * | 1995-06-07 | 2000-02-08 | Cor Therapeutics, Inc. | Ketoheterocyclic inhibitors of factor Xa |
IL119466A (en) | 1995-11-03 | 2001-08-26 | Akzo Nobel Nv | Thrombin inhibitors, their preparation and pharmaceutical compositions containing them |
TW523513B (en) | 1996-03-01 | 2003-03-11 | Akzo Nobel Nv | Serine protease inhibitors |
NZ332740A (en) | 1996-06-18 | 2000-05-26 | Warner Lambert Co | heterocyclically substituted carbamate or sulphonamide derivatives |
IL121474A0 (en) | 1996-08-23 | 1998-02-08 | Akzo Nobel Nv | Thrombin inhibitors |
UA79749C2 (en) * | 1996-10-18 | 2007-07-25 | Vertex Pharma | Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
HUP0100669A3 (en) | 1996-12-06 | 2001-12-28 | Cortech Inc Denver | Peptide derivatives as serine protease inhibitors, their use and pharmaceutical compositions comprising thereof |
US6004933A (en) | 1997-04-25 | 1999-12-21 | Cortech Inc. | Cysteine protease inhibitors |
WO1998050420A1 (en) | 1997-05-02 | 1998-11-12 | Akzo Nobel N.V. | Serine protease inhibitors |
IL134233A0 (en) | 1997-08-11 | 2001-04-30 | Boehringer Ingelheim Ca Ltd | Hepatitis c inhibitor peptide analogues |
US6323219B1 (en) * | 1998-04-02 | 2001-11-27 | Ortho-Mcneil Pharmaceutical, Inc. | Methods for treating immunomediated inflammatory disorders |
EP1114822A3 (en) | 1998-06-03 | 2002-11-13 | Cortech Inc. | Indoles and tetrahydroisoquinolines containing alpha-keto oxadiazoles as serine protease inhibitors |
US6242422B1 (en) | 1998-10-22 | 2001-06-05 | Idun Pharmacueticals, Inc. | (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
KR20000047461A (ko) | 1998-12-29 | 2000-07-25 | 성재갑 | 트롬빈 억제제 |
HUP0201295A3 (en) * | 1999-01-27 | 2002-10-28 | Ortho Mcneil Pharm Inc | Peptidyl heterocyclic ketones useful as tryptase inhibitors |
JP2000256396A (ja) * | 1999-03-03 | 2000-09-19 | Dainippon Pharmaceut Co Ltd | 複素環式化合物およびその中間体ならびにエラスターゼ阻害剤 |
GB9929552D0 (en) | 1999-12-14 | 2000-02-09 | Proteus Molecular Design | Compounds |
EP1196436A2 (en) | 1999-07-07 | 2002-04-17 | Bristol-Myers Squibb Pharma Company | Peptide boronic acid inhibitors of hepatitis c virus protease |
GB9923710D0 (en) | 1999-10-08 | 1999-12-08 | Proteus Molecular Design | Chemical compounds |
US6774212B2 (en) | 1999-12-03 | 2004-08-10 | Bristol-Myers Squibb Pharma Company | Alpha-ketoamide inhibitors of hepatitis C virus NS3 protease |
US7244721B2 (en) | 2000-07-21 | 2007-07-17 | Schering Corporation | Peptides as NS3-serine protease inhibitors of hepatitis C virus |
PL206255B1 (pl) | 2000-07-21 | 2010-07-30 | Dendreon Corporationdendreon Corporation | Inhibitor proteazy wirusa zapalenia wątroby C, zawierająca go kompozycja farmaceutyczna i zastosowanie inhibitora do wytwarzania leku do leczenia chorób związanych z HCV oraz zastosowanie do wytwarzania kompozycji do stosowania w kombinowanej terapii |
JP2002138048A (ja) * | 2000-08-25 | 2002-05-14 | Dainippon Pharmaceut Co Ltd | 複素環式化合物からなる医薬 |
SV2003000617A (es) | 2000-08-31 | 2003-01-13 | Lilly Co Eli | Inhibidores de la proteasa peptidomimetica ref. x-14912m |
WO2003006490A1 (en) | 2001-07-11 | 2003-01-23 | Vertex Pharmaceuticals Incorporated | Bridged bicyclic serine protease inhibitors |
WO2003072528A2 (en) | 2002-02-08 | 2003-09-04 | Idun Pharmaceuticals, Inc. | (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
US7205384B2 (en) | 2003-08-05 | 2007-04-17 | Ortho-Mcneil Pharmaceutical Inc. | Process for preparing peptidyl heterocyclic ketone derivatives |
AR045596A1 (es) | 2003-09-05 | 2005-11-02 | Vertex Pharma | Inhibidores de proteasas de serina en particular proteasa ns3-ns4a del vhc |
NZ546663A (en) | 2003-10-10 | 2010-01-29 | Vertex Pharma | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
KR20060118532A (ko) | 2003-12-11 | 2006-11-23 | 쉐링 코포레이션 | C형 간염 바이러스 ns3/ns4a 세린 프로테아제의억제제 |
WO2005076886A2 (en) | 2004-02-05 | 2005-08-25 | Irm Llc | Prostasin substrates and inhibitors |
TW200602037A (en) | 2004-02-27 | 2006-01-16 | Schering Corp | Novel compounds as inhibitors of hepatitis C virus NS3 serine protease |
BRPI0509150B8 (pt) | 2004-03-24 | 2021-05-25 | Jerini Ag | compostos para a inibição de angiogênese e uso destes |
MXPA06013404A (es) * | 2004-05-20 | 2007-01-23 | Schering Corp | Prolinas sustituidas como inhibidores de serina proteasa ns3 de virus de hepatitis c. |
JPWO2006006644A1 (ja) | 2004-07-14 | 2008-05-01 | 協和醗酵工業株式会社 | 複素環式化合物 |
GB0507577D0 (en) | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
US20060275366A1 (en) * | 2005-06-02 | 2006-12-07 | Schering Corporation | Controlled-release formulation |
WO2007137080A2 (en) * | 2006-05-23 | 2007-11-29 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
WO2007140117A1 (en) | 2006-05-23 | 2007-12-06 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
DK2104535T3 (da) * | 2007-01-10 | 2011-04-04 | Irm Llc | Forbindelser og sammensætninger som kanalaktiverende proteaseinhibitorer |
JP2010518099A (ja) | 2007-02-09 | 2010-05-27 | アイアールエム・リミテッド・ライアビリティ・カンパニー | チャネル活性化プロテアーゼ阻害剤としての化合物および組成物 |
JP2010518097A (ja) * | 2007-02-09 | 2010-05-27 | アイアールエム・リミテッド・ライアビリティ・カンパニー | チャネル活性化プロテアーゼ阻害剤としての化合物および組成物 |
-
2008
- 2008-01-07 JP JP2009549151A patent/JP2010518099A/ja not_active Ceased
- 2008-01-07 EA EA200901083A patent/EA016327B1/ru not_active IP Right Cessation
- 2008-01-07 MX MX2009008518A patent/MX2009008518A/es not_active Application Discontinuation
- 2008-01-07 KR KR1020097018742A patent/KR20090108131A/ko active IP Right Grant
- 2008-01-07 BR BRPI0807483-6A2A patent/BRPI0807483A2/pt not_active IP Right Cessation
- 2008-01-07 CN CNA2008800038800A patent/CN101600428A/zh active Pending
- 2008-01-07 AU AU2008214217A patent/AU2008214217B2/en not_active Ceased
- 2008-01-07 EP EP08727380A patent/EP2117537A1/en not_active Withdrawn
- 2008-01-07 WO PCT/US2008/050403 patent/WO2008097676A1/en active Application Filing
- 2008-01-07 US US12/526,029 patent/US8293915B2/en not_active Expired - Fee Related
- 2008-01-07 CA CA002677487A patent/CA2677487A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BRPI0807483A2 (pt) | 2014-05-13 |
AU2008214217A1 (en) | 2008-08-14 |
CN101600428A (zh) | 2009-12-09 |
KR20090108131A (ko) | 2009-10-14 |
EA200901083A1 (ru) | 2010-02-26 |
JP2010518099A (ja) | 2010-05-27 |
AU2008214217B2 (en) | 2011-10-13 |
EP2117537A1 (en) | 2009-11-18 |
CA2677487A1 (en) | 2008-08-14 |
US20100056756A1 (en) | 2010-03-04 |
EA016327B1 (ru) | 2012-04-30 |
WO2008097676A1 (en) | 2008-08-14 |
US8293915B2 (en) | 2012-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2009000294A1 (en) | Compounds and compositions as channel activating protease inhibitors | |
MX2009008493A (es) | Compuestos y composiciones como inhibidores de la proteasa activadora de canal. | |
MX2009008518A (es) | Compuestos y composiciones como inhibidores de la proteasa activadora de canal. | |
WO2007137080A3 (en) | Compounds and compositions as channel activating protease inhibitors | |
WO2007079096A3 (en) | Protease inhibition | |
SE0201980D0 (sv) | Novel compounds | |
MX2009008925A (es) | Compuestos de la formula (i) como inhibidores de proteasa de serina. | |
MX2010008523A (es) | Inhibidores macrociclicos de serina proteasa. | |
UA74372C2 (uk) | Інгібітори серинових протеаз, фармацевтична композиція на їх основі | |
UA98647C2 (en) | Kallikrein-7 modulators | |
CY1110980T1 (el) | Εμβολιο συνδυασμων πεπτιδιων εναντια στην αλλεργια απο γατες | |
MX2009002960A (es) | Inhibidores de serina hidrolasa. | |
GB0222722D0 (en) | Enzyme-sensitive therapeutic wound dressings | |
MX2008002493A (es) | Composicion farmaceutica solida que comprende 1-(4-cloro-anilino)-4-(4-piridil-metil)-ftalazina y un modificador del ph. | |
TNSN06021A1 (en) | Combinations of cathepsin k inhibitor and a bisphosphonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss | |
TW200700057A (en) | Alpha ketoamide compounds as cysteine protease inhibitors | |
EP1694647A4 (en) | INHIBITORS OF CYSTEINE PROTEASES OF THE CATHEPSIN TYPE | |
ZA202201931B (en) | Pinctada martensii fucata kunitz-type serine protease inhibitor gene, protein encoded thereby, and use thereof | |
UY30629A1 (es) | Nuevo péptido de actinomadura namibiensis | |
EP1673336A4 (en) | INHIBITORS OF CATHEPSIN AND CYSTEINE PROTEASE | |
DK1292673T3 (da) | Trombomodulinanaloger til farmaceutisk anvendelse | |
WO2005063742A3 (en) | Amidino compounds as cysteine protease inhibitors | |
MY157366A (en) | Therapies and compositions comprising cathepsin s antibodies | |
UA95502C2 (ru) | Соединения и композиция как ингибиторы активирующей каналы протеазы | |
SE0203712D0 (sv) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |